Clinical trial
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
NCT04071847
Study timeline
Study start (actual)2019-11-26Date precision: day
Registry last updated2026-01-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Movement Disordersunresolved
Parkinson Diseaseunresolved
Essential Tremorunresolved
Tremorunresolved
Dystoniaunresolved
Primary Dystoniaunresolved
Secondary Dystoniaunresolved
Interventions
Sponsors & collaborators
Abbott Medical Deviceslead sponsor
Mapped research locations
BostonMassachusetts, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1MiamiFlorida, United States1MadridSpain1LondonUnited Kingdom1ClevelandOhio, United States1PittsburghPennsylvania, United States1ColumbusOhio, United States1TampaFlorida, United States1IndianapolisIndiana, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04071847 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.